Dividend King Growth Giant: J&J Faces Lilly Challenge
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Understanding the value of points versus cash back helps you make smart financial choices. Compare both to see which is more beneficial.
28,655 articlesJohnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Fidelity Enhanced International ETF (FENI) continues to pay a quarterly dividend funded by profits from more than 350...
Elon Musk took the stand in a Delaware court as Twitter shareholders pursue damages over pre-purchase disclosures. Th...
A Gen Z hiring manager recounts a disruptive interview moment that sparks a broader debate over professionalism and e...
Occidental Petroleum leads the 2026 performance among three top U.S. energy explorers, with EOG Resources and ConocoP...
A recent celebrity confession grabs headlines, but the real takeaway is how fast income can rise and how to handle we...
Coinbase is expanding beyond its USDC partnership by joining a large coalition backing a new stablecoin. This shift c...
A CEO’s large stock sale can spark questions about a company’s trajectory. This guide breaks down what genomics sells...
A record Bitcoin buy signals a shift in 2026. Big buyers are reshaping STRC demand and influencing crypto markets. He...
A stronger-than-expected jobs report unleashed a broad market selloff, wiping $1.4 trillion from S&P 500 valuations a...
XRP trimmed gains after a brief rise above $1.60, but fresh ETF inflows and renewed whale buying point to near-term u...
Tech shares dragged the Nasdaq into negative territory on March 24, as investors weighed higher yields and cautious g...